Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP)
To report on imatinib mesylate (IM) in patients with metastatic dermatofibrosarcoma protuberans (DFSP)/fibrosarcomatous (FS)-DFSP and on the impact of the treatment on tumor biology.Ten consecutive patients treated with IM from 2007 to 2015 for a metastatic relapse from DFSP/FS-DFSP were identified....
I tiakina i:
Ngā kaituhi matua: | , , , , , , , , , , , , , , , , , , |
---|---|
Hōputu: | Artigo |
Reo: | Ingarihi |
I whakaputaina: |
2015
|
Urunga tuihono: | https://doi.org/10.1158/1078-0432.ccr-15-1243 |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|